Reported outcomes in patients with iron deficiency or iron deficiency anemia undergoing major surgery: a systematic review of outcomes.
Core outcome set
Data harmonization
Iron deficiency
Iron deficiency anemia
Outcome reporting
Perioperative setting
Preoperative setting
Surgery
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
02 Jan 2024
02 Jan 2024
Historique:
received:
22
03
2023
accepted:
11
12
2023
medline:
4
1
2024
pubmed:
4
1
2024
entrez:
3
1
2024
Statut:
epublish
Résumé
Iron deficiency (ID) is the leading cause of anemia worldwide. The prevalence of preoperative ID ranges from 23 to 33%. Preoperative anemia is associated with worse outcomes, making it important to diagnose and treat ID before elective surgery. Several studies indicated the effectiveness of intravenous iron supplementation in iron deficiency with or without anemia (ID(A)). However, it remains challenging to establish reliable evidence due to heterogeneity in utilized study outcomes. The development of a core outcome set (COS) can help to reduce this heterogeneity by proposing a minimal set of meaningful and standardized outcomes. The aim of our systematic review was to identify and assess outcomes reported in randomized controlled trials (RCTs) and observational studies investigating iron supplementation in iron-deficient patients with or without anemia. We searched MEDLINE, CENTRAL, and ClinicalTrials.gov systematically from 2000 to April 1, 2022. RCTs and observational studies investigating iron supplementation in patients with a preoperative diagnosis of ID(A), were included. Study characteristics and reported outcomes were extracted. Outcomes were categorized according to an established outcome taxonomy. Quality of outcome reporting was assessed with a pre-specified tool. Reported clinically relevant differences for sample size calculation were extracted. Out of 2898 records, 346 underwent full-text screening and 13 studies (five RCTs, eight observational studies) with sufficient diagnostic inclusion criteria for iron deficiency with or without anemia (ID(A)) were eligible. It is noteworthy to mention that 49 studies were excluded due to no confirmed diagnosis of ID(A). Overall, 111 outcomes were structured into five core areas including nine domains. Most studies (92%) reported outcomes within the 'blood and lymphatic system' domain, followed by "adverse event" (77%) and "need for further resources" (77%). All of the latter reported on the need for blood transfusion. Reported outcomes were heterogeneous in measures and timing. Merely, two (33%) of six prospective studies were registered prospectively of which one (17%) showed no signs of selective outcome reporting. This systematic review comprehensively depicts the heterogeneity of reported outcomes in studies investigating iron supplementation in ID(A) patients regarding exact definitions and timing. Our analysis provides a systematic base for consenting to a minimal COS. PROSPERO CRD42020214247.
Sections du résumé
BACKGROUND
BACKGROUND
Iron deficiency (ID) is the leading cause of anemia worldwide. The prevalence of preoperative ID ranges from 23 to 33%. Preoperative anemia is associated with worse outcomes, making it important to diagnose and treat ID before elective surgery. Several studies indicated the effectiveness of intravenous iron supplementation in iron deficiency with or without anemia (ID(A)). However, it remains challenging to establish reliable evidence due to heterogeneity in utilized study outcomes. The development of a core outcome set (COS) can help to reduce this heterogeneity by proposing a minimal set of meaningful and standardized outcomes. The aim of our systematic review was to identify and assess outcomes reported in randomized controlled trials (RCTs) and observational studies investigating iron supplementation in iron-deficient patients with or without anemia.
METHODS
METHODS
We searched MEDLINE, CENTRAL, and ClinicalTrials.gov systematically from 2000 to April 1, 2022. RCTs and observational studies investigating iron supplementation in patients with a preoperative diagnosis of ID(A), were included. Study characteristics and reported outcomes were extracted. Outcomes were categorized according to an established outcome taxonomy. Quality of outcome reporting was assessed with a pre-specified tool. Reported clinically relevant differences for sample size calculation were extracted.
RESULTS
RESULTS
Out of 2898 records, 346 underwent full-text screening and 13 studies (five RCTs, eight observational studies) with sufficient diagnostic inclusion criteria for iron deficiency with or without anemia (ID(A)) were eligible. It is noteworthy to mention that 49 studies were excluded due to no confirmed diagnosis of ID(A). Overall, 111 outcomes were structured into five core areas including nine domains. Most studies (92%) reported outcomes within the 'blood and lymphatic system' domain, followed by "adverse event" (77%) and "need for further resources" (77%). All of the latter reported on the need for blood transfusion. Reported outcomes were heterogeneous in measures and timing. Merely, two (33%) of six prospective studies were registered prospectively of which one (17%) showed no signs of selective outcome reporting.
CONCLUSION
CONCLUSIONS
This systematic review comprehensively depicts the heterogeneity of reported outcomes in studies investigating iron supplementation in ID(A) patients regarding exact definitions and timing. Our analysis provides a systematic base for consenting to a minimal COS.
SYSTEMATIC REVIEW REGISTRATION
BACKGROUND
PROSPERO CRD42020214247.
Identifiants
pubmed: 38167004
doi: 10.1186/s13643-023-02431-x
pii: 10.1186/s13643-023-02431-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5Informations de copyright
© 2023. The Author(s).
Références
World Health O. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: World Health Organization; 2011.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602.
doi: 10.1016/S0140-6736(16)31678-6
Judd L, Hof L, Beladdale L, Friederich P, Thoma J, Wittmann M, et al. Prevalence of pre-operative anaemia in surgical patients: a retrospective, observational, multicentre study in Germany. Anaesthesia. 2022;77(11):1209–18.
doi: 10.1111/anae.15847
pubmed: 36108174
Tonino RPB, Wilson M, Zwaginga JJ, Schipperus MR. Prevalence of iron deficiency and red blood cell transfusions in surgical patients. Vox Sang. 2022;117(3):379–85.
doi: 10.1111/vox.13194
pubmed: 34427343
Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg. 2015;102(11):1314–24.
doi: 10.1002/bjs.9861
pubmed: 26349842
Muñoz M, Gómez-Ramírez S, Campos A, Ruiz J, Liumbruno GM. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood Transfus. 2015;13(3):370.
pubmed: 26192787
pmcid: 4614288
WHO guidelines approved by the guidelines review committee. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: World Health Organization © World Health Organization 2020; 2020.
Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015;102(6):1585–94.
doi: 10.3945/ajcn.114.103366
pubmed: 26561626
Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC). Eur Heart J. 2022;43(39):3826–924.
doi: 10.1093/eurheartj/ehac270
pubmed: 36017553
Meybohm P, Choorapoikayil S, Regaei A, Jung-König M, Zacharowski K. Patient blood management. ISBT Sci Ser. 2019;14(1):53–7.
doi: 10.1111/voxs.12456
Neef V, Choorapoikayil S, Piekarski F, Schlesinger T, Meybohm P, Zacharowski K. Current concepts in the evaluation and management of preoperative anemia. Curr Opin Anaesthesiol. 2021;34(3):352–6.
doi: 10.1097/ACO.0000000000000979
pubmed: 33935184
Elhenawy AM, Meyer SR, Bagshaw SM, MacArthur RG, Carroll LJ. Role of preoperative intravenous iron therapy to correct anemia before major surgery: a systematic review and meta-analysis. Syst Rev. 2021;10(1):36.
doi: 10.1186/s13643-021-01579-8
pubmed: 33485392
pmcid: 7824930
Ng O, Keeler BD, Mishra A, Simpson JA, Neal K, Al-Hassi HO, et al. Iron therapy for preoperative anaemia. Cochrane Database Syst Rev. 2019;12(12):CD011588. https://doi.org/10.1002/14651858.CD011588.pub3 .
Van Remoortel H, Laermans J, Avau B, Bekkering G, Georgsen J, Manzini PM, et al. Effectiveness of iron supplementation with or without erythropoiesis-stimulating agents on red blood cell utilization in patients with preoperative anaemia undergoing elective surgery: a systematic review and meta-analysis. Transfus Med Rev. 2021;35(2):103–24.
doi: 10.1016/j.tmrv.2021.03.004
pubmed: 33965294
Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET handbook: version 1.0. Trials. 2017;18(3):1–50.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.
doi: 10.1136/bmj.n71
pubmed: 33782057
pmcid: 8005924
Systematic review of outcomes reported in clinical trials addressing iron deficiency and iron deficiency anaemia in patients undergoing surgery. Version: 13 November 2020, https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020214247 .
Dodd S, Clarke M, Becker L, Mavergames C, Fish R, Williamson PR. A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery. J Clin Epidemiol. 2018;96:84–92.
doi: 10.1016/j.jclinepi.2017.12.020
pubmed: 29288712
pmcid: 5854263
Outcome Taxonomy User Guide. https://community.cochrane.org/sites/default/files/uploads/Outcome%20Taxonomy%20User%20Guide.pdf .
Harman NL, Bruce IA, Callery P, Tierney S, Sharif MO, O'Brien K, et al. MOMENT--Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2013;14:70.
doi: 10.1186/1745-6215-14-70
pubmed: 23497540
pmcid: 3716725
Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg. 2016;264(1):41.
doi: 10.1097/SLA.0000000000001646
pubmed: 26817624
Kim YH, Chung HH, Kang SB, Kim SC, Kim YT. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. Acta Haematol. 2009;121(1):37–41.
doi: 10.1159/000210062
pubmed: 19332985
Lee S, Ryu K-J, Lee ES, Lee KH, Lee JJ, Kim T. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: an open-label, multicenter, randomized study. J Obstet Gynaecol Res. 2019;45(4):858–64.
doi: 10.1111/jog.13893
pubmed: 30932300
Na H-S, Shin S-Y, Hwang J-Y, Jeon Y-T, Kim C-S, Do S-H. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty (CME). Transfusion. 2011;51(1):118–24.
doi: 10.1111/j.1537-2995.2010.02783.x
pubmed: 20624257
Thin TN, Tan BPY, Sim EY, Shum KL, Chan HSP, Abdullah HR. Preoperative single-dose intravenous iron formulation to reduce postsurgical complications in patients undergoing major abdominal surgery: a randomized control trial feasibility study (PIRCAS Trial Pilot). Cureus. 2021;13(8):e17357.
pubmed: 34567897
pmcid: 8452824
Nandhra S, Chau M, Klein AA, Yeates JA, Collier T, Evans C, et al. Preoperative anaemia management in patients undergoing vascular surgery. Br J Surg. 2020;107(12):1558–61.
pubmed: 32996596
Klein AA, Chau M, Yeates JA, Collier T, Evans C, Agarwal S, et al. Preoperative intravenous iron before cardiac surgery: a prospective multicentre feasibility study. Br J Anaesth. 2020;124(3):243–50.
doi: 10.1016/j.bja.2019.11.023
pubmed: 31902590
Abdullah HR, Thamnachit T, Hao Y, Lim WY, Teo LM, Sim YE. Real-world results of the implementation of preoperative anaemia clinic with intravenous iron therapy for treating iron-deficiency anaemia: a propensity-matched case-control study. J Transl Med. 2020;9(1):6.
D'Amato T, Kon E, Martorelli F, Monteleone G, Simili V, Tasso F, et al. Effect of intravenous ferric carboxymaltose supplementation in non-anaemic iron deficient patients undergoing hip and knee arthroplasty. J Biol Regul Homeost Agents. 2020;34(4 Suppl. 3):69–77. Congress of the Italian Orthopaedic Research Society.
pubmed: 33261258
Ionescu A, Sharma A, Kundnani NR, Mihăilescu A, David VL, Bedreag O, et al. Intravenous iron infusion as an alternative to minimize blood transfusion in peri-operative patients. Sci Rep. 2020;10(1):18403.
doi: 10.1038/s41598-020-75535-2
pubmed: 33110237
pmcid: 7591902
Laso-Morales M, Jericó C, Gómez-Ramírez S, Castellví J, Viso L, Roig-Martínez I, et al. Preoperative management of colorectal cancer–induced iron deficiency anemia in clinical practice: data from a large observational cohort. Transfusion. 2017;57(12):3040–8.
doi: 10.1111/trf.14278
pubmed: 28833205
Scardino M, Di Matteo B, Martorelli F, Tanzi D, Kon E, D’Amato T. Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. Int Orthop. 2019;43(1):39–46.
doi: 10.1007/s00264-018-4149-7
pubmed: 30232527
Shin K-H, Park J-H, Jang K-M, Hong S-H, Han S-B. Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty. Arthroplasty. 2020;2(1):22.
doi: 10.1186/s42836-020-00041-9
pubmed: 35236435
pmcid: 8796593
The Helsinki Declaration of the World Medical Association (WMA). Ethical principles of medical research involving human subjects. Pol Merkur Lekarski. 2014;36(215):298–301.
Shander A, Corwin HL, Meier J, Auerbach M, Bisbe E, Blitz J, et al. Recommendations from the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS). Ann Surg. 2022;277(4):581–90.
doi: 10.1097/SLA.0000000000005721
pubmed: 36134567
Kaufner L, von Heymann C, Henkelmann A, Pace NL, Weibel S, Kranke P, et al. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2020;8(8):Cd012451.
pubmed: 32790892
Triphaus C, Judd L, Glaser P, Goehring MH, Schmitt E, Westphal S, et al. Effectiveness of preoperative iron supplementation in major surgical patients with iron deficiency: a prospective observational study. Ann Surg. 2021;274(3):e212–9.
doi: 10.1097/SLA.0000000000003643
pubmed: 31939751
Richards T, Baikady RR, Clevenger B, Butcher A, Abeysiri S, Chau M, et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet. 2020;396(10259):1353–61.
doi: 10.1016/S0140-6736(20)31539-7
pubmed: 32896294
pmcid: 7581899
Malinowski AK, D'Souza R, Khan KS, Shehata N, Malinowski M, Daru J. Reported outcomes in perinatal iron deficiency anemia trials: a systematic review. Gynecol Obstet Investig. 2019;84(5):417–34.
doi: 10.1159/000495566
Moussa R, Rada MP, Durnea C, Falconi G, Betschart C, Haddad JM, et al. Outcome reporting in randomized controlled trials (RCTs) on the pharmacological management of idiopathic overactive bladder (OAB) in women; a systematic review for the development of core outcome sets (COS). Int Urogynecol J. 2022;33(5):1243–50.
doi: 10.1007/s00192-021-05040-1
pubmed: 35006311
pmcid: 9120103
Tellum T, Omtvedt M, Naftalin J, Hirsch M, Jurkovic D. A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis. Hum Reprod Open. 2021;2021(3):hoab030.
doi: 10.1093/hropen/hoab030
pubmed: 34466664
pmcid: 8398753